SMARCA4 and endometrial carcinoma: For example, in combination with a panel of other molecular features, SMARCA4 has become a novel tool to discern between SMARCA4-deficient undifferentiated uterine sarcoma and undifferentiated and dedifferentiated endometrial carcinomas (generally expressing intact SMARCA4).